Authors: Allison Stevens, Gennie Parkman
Mentors: Gennie Parkman
Insitution: Weber State University
The principal genes that are responsible for the conversion of benign nevi, or pigmented lesions, to cancerous melanomas have been discovered and validated. However, we are still identifying the additional genetic alterations that are responsible for the migration and invasion of melanoma cells and ultimately metastasis of these melanomas as that is where treatment needs remain. (Davies, et al., 2002)
One gene that has been identified to potentially play a role in the metastasis of melanoma is thymocyte selection associated high mobility group box, or TOX. Based on one study, the levels of TOX gene expression were found to be elevated in melanoma brain metastases versus extracranial metastases (Bierman et al., 2022). These findings have led us to hypothesize that TOX plays a role in the migration and invasion of melanoma into the brain. Preliminary work has been completed to clone our gene of interest, TOX, into an expression vector and transduce mammalian melanoma cells to evaluate their effects on melanoma cell rate growth and migration. These experiments will identify the effect of TOX on the initiation and progression of melanoma cells through in vitro melanoma cell culture and experimentation before potentially progressing to well-validated mouse models of melanoma.